<DOC>
	<DOCNO>NCT01387464</DOCNO>
	<brief_summary>The purpose study evaluate aqueous humor concentration bromfenac sodium subject administer multiple topical ocular dos ISV-303 Bromdayâ„¢ QD prior routine cataract surgery .</brief_summary>
	<brief_title>Aqueous Humor Concentration InSite Vision ( ISV ) 303 ( Bromfenac DuraSite ) Bromday Once Daily ( QD ) Prior Cataract Surgery</brief_title>
	<detailed_description />
	<mesh_term>Cataract</mesh_term>
	<mesh_term>Bromfenac</mesh_term>
	<criteria>Male female subject age 18 old schedule unilateral cataract surgery ( phacoemulsification extracapsular extraction ) posterior chamber intraocular lens implantation If female childbearing potential , subject must agree submit urine sample pregnancy test Visit 1 prior enrollment end study , subject must use effective contraception duration study . Post menopausal define menses least 12 consecutive month . Signature subject Informed Consent Form Willing able follow instruction attend study visit Able selfadminister study drug ( caregiver available instill dos study drug ) Use drug contain bromfenac within 2 week prior surgery Contact lens wear dosing period Known hypersensitivity poor tolerance bromfenac sodium component investigational medicinal product ( IMP ) procedural medication Any serious complication macroscopic damage corneal epithelium Currently pregnant , nursing , plan pregnancy ; woman positive urine pregnancy test Currently suffer alcohol and/or drug abuse Prior participation study protocol Prior ( within 30 day begin study treatment ) anticipate concurrent use investigational drug device A condition situation , investigator 's opinion may put subject increase risk , confound study data , interfere significantly subject 's study participation</criteria>
	<gender>All</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>N/A</maximum_age>
	<verification_date>June 2016</verification_date>
	<keyword>bromfenac concentration</keyword>
	<keyword>ISV-303</keyword>
	<keyword>Bromday</keyword>
</DOC>